Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention

Area of Science:

• Cardiology
• Neurology
• Medical Devices

Background:

• Patent foramen ovale (PFO) is prevalent, particularly in cryptogenic stroke patients.
• PFO's role in paradoxical embolism and stroke causation is debated.
• Percutaneous PFO closure is increasingly considered for secondary stroke prevention.

Purpose of the Study:

• To review current evidence on PFO closure for secondary stroke prevention.
• To identify patient selection criteria for optimal benefit.
• To inform future guideline statements and device approvals.

Main Methods:

• Review of current scientific evidence and clinical trial data.
• Analysis of patient characteristics associated with stroke risk and closure benefit.
• Evaluation of the impact of patient selection on outcomes.

Main Results:

• Benefit from PFO closure is contingent upon careful patient selection.
• Ideal candidates are under 60 with few vascular risk factors and embolic stroke.
• Thorough evaluation is necessary to confirm cryptogenic stroke etiology.

Conclusions:

• Patient selection is crucial for successful PFO closure in stroke prevention.
• Future trials and guidelines should emphasize precise patient selection criteria.
• Optimizing patient selection will enhance clinical decision-making and trial efficacy.